FDA Launches FAERS Dashboard for Cosmetic Product Adverse Event

On 12 September 2025, The U.S. Food and Drug Administration (FDA) has launched the FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products, an interactive platform designed to provide real-time access to adverse event reports related to cosmetic products. The launch, announced via a FDA press release, supports the FDA’s broader modernization strategy and responds to growing demand for transparency in product safety.

The dashboard covers a wide range of cosmetic categories, such as moisturizers, shampoos, conditioners, hair dyes, and tattoos.

FDA Adverse Event Reporting System (FAERS)

The launch of the cosmetic products dashboard is part of the FDA’s borader push for transparency, complementing earlier initiatives such as real-time reporting of adverse events and medication errors for drugs and therapeutic biologics.

The new platform centralizes reports exclusively related to cosmetic products, including those required under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) and voluntary submissions from healthcare professionals, consumers, and cosmetic industry professionals.

Key Features of the FAERS Dashboard

• Real-time Access: Reports updated daily with downloadable datasets.
• Comprehensive Search: Filter by product, event, severity, date, or type.
• Public Transparency: Addresses demand for safety visibility.
• Limitations: Reports are unverified and do not establish causation or confirm product safety.



Stakeholder Obligationsunder MoCRA

MoCRA requires companies are required to submit serious adverse event reports for cosmetic products to the FDA. Other stakeholders, inlcuding healthcare professionals, salon professionals, cosmetologists, and consumers are encouraged to voluntarily report incidents to strengthen safety surveillance.

While the dashboard enhances transparency, the FDA notes that the data is intended for monitoring purposes only.  Companies are expected to evaluate safety signals proactively and take mitigation measures when risks are identified.